Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125510081 | 12551008 | 1 | I | 20160521 | 20160701 | 20160713 | 20160713 | EXP | GB-BAXTER-2016BAX035586 | BAXTER | 0.00 | Y | 0.00000 | 20160712 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125510081 | 12551008 | 1 | PS | METRONIDAZOLE 500 MG / 100 ML INTRAVENOUS INFUSION | METRONIDAZOLE | 1 | Intravenous (not otherwise specified) | U | 0 | SOLUTION FOR INFUSION | |||||||||
| 125510081 | 12551008 | 2 | SS | CEFUROXIME. | CEFUROXIME | 1 | Intravenous (not otherwise specified) | U | 0 | 750 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125510081 | 12551008 | 1 | Antibiotic therapy |
| 125510081 | 12551008 | 2 | Antibiotic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125510081 | 12551008 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125510081 | 12551008 | Blood pressure decreased | |
| 125510081 | 12551008 | Dizziness | |
| 125510081 | 12551008 | Drug hypersensitivity | |
| 125510081 | 12551008 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |